Skip to main content

Table 1 The association between CRI and the risk factors (univariate analysis)

From: Central venous catheter related infections: Risk factors and the effect of glycopeptide antibiotics

Risk groups Total CRI RR* (%95 CI**) p value
  n (%) n (%)    
Unit        
Surgical ICU 92 (30.7) 20 (21.7) 1.53 (0.90–2.60) 0.12
Neurosurgical ICU 32 (10.7) 5 (15.6) 1.10 (0.46–2.66) 0.79
Medical ICU 176 (58.6) 25 (14.2) 1.00   
Gender        
Male 148 (49.3) 25 (16.9) 1.03 (0.62–1.70) 0.92
Female 152 (50.7) 25 (16.4) 1.00   
CVC insertion site        
Jugular vein 132 (44) 30 (22.7) 1.91 (1.14–3.20) 0.01
Subclavian vein 168 (56) 20 (11.9) 1.00   
Repeated catheterization        
Subsequent catheters 197 (65.7) 34 (17.2) 1.13 (0.54–2.72) 0.87
First catheter inserted 103 (34.3) 16 (15.5) 1.00   
Total parenteral nutrition        
No 272 (90.7) 46 (16.9) 1.18 (0.46–3.05) 0.99
Yes 28 (9.3) 4 (14.3) 1.00   
Primary diagnosis        
Cardiorespiratory failure 81 (27) 14 (19.4) 0.97 (0.51–1.87) 0.93
Trauma 72 (24) 9 (12.5) 0.63 (0.29–1.34) 0.22
Postsurgical 72 (24) 12 (14.8) 0.74 (0.37–1.48) 0.39
Others 75 (25) 15 (20.0) 1.00   
Duration of catheterization        
≥ 8 day 99 (33) 24 (24.2) 1.87 (1.14–3.09) 0.01
≤ 7 day 201 (67) 26 (12.9) 1.00   
Glycopeptide usage        
No 187 (62.4) 45 (24.0) 4.45 (1.46–3.14) 0.001
Yes 113 (37.6) 5 (4.4) 1.00   
  1. RR*: Risk ratio 95%CI**: 95% confidence interval
\